Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus

Pech, O.; Behrens, A.; May, A.; Nachbar, L.; Gossner, L.; Rabenstein, T.; Manner, H.; Guenter, E.; Huijsmans, J.; Vieth, M.; Stolte, M.; Eli, C.
September 2008
Gut;Sep2008, Vol. 57 Issue 9, p1200
Academic Journal
Objective: Endoscopic therapy is increasingly being used in the treatment of high-grade intraepithelial neoplasia (HGIN) and mucosal adenocarcinoma (BC) in patients with Barrett's oesophagus. This report provides 5 year follow-up data from a large prospective study investigating the efficacy and safety of endoscopic treatment in these patients and analysing risk factors for recurrence. Design: Prospective case series. Setting: Academic tertiary care centre. Patients: Between October 1996 and September 2002, 61 patients with HGIN and 288 with BC were included (173 with short-segment and 176 with long-segment Barrett's oesophagus) from a total of 486 patients presenting with Barrett's neoplasia. Patients with submucosal or more advanced cancer were excluded. Interventions: Endoscopic therapy. Main outcome measures: Rate of complete remission and recurrence rate, tumour-associated death. Results: Endoscopic resection was performed in 279 patients, photodynamic therapy in 55, and both procedures in 13; two patients received argon plasma coagulation. The mean follow-up period was 63.6 (SD 23.1) months. Complete response (CR) was achieved in 337 patients {96.6%l; surgery was necessary in 13 (3.7%) after endoscopic therapy failed. Metachronous lesions developed during the follow-up in 74 patients (21.5%); 56 died of concomitant disease, but none died of BC. The calculated 5 year survival rate was 84%. The risk factors most frequently associated with recurrence were piecemeal resection, long-segment Barrett's oesophagus, no ablative therapy of Barrett's oesophagus after CR, time until CR achieved >10 months and multifocal neoplasia. Conclusions: This study showed that endoscopic therapy was highly effective and safe, with an excellent long-term survival rate. The risk factors identified may help stratify patients who are at risk for recurrence and those requiring more intensified follow-up.


Related Articles

  • Can clinical and endoscopic findings accurately predict early-stage adenocarcinoma? Portale, G.; Peters, J. H.; Hsieh, C.-C.; Hagen, J. A.; DeMeester, S. R; DeMeester, T. R. // Surgical Endoscopy;Feb2006, Vol. 20 Issue 2, p294 

    Background: The presentation and management of esophageal cancer are changing, as more patients are diagnosed at an earlier stage of the disease in which endoscopic treatment methods may be contemplated. Therefore, we conducted a study to determine whether symptomatic and endoscopic findings can...

  • Endoscopic therapy outperforms surgery for oesophageal cancer.  // PharmacoEconomics & Outcomes News;11/28/2009, Issue 592, p8 

    The article discusses research on the cost benefit of endoscopic therapy against surgery for early Barrett's oesophagus carcinoma. It references a study by H. Pohl et al, published in the October 2009 issue of the journal "Gastrointestinal Endoscopy." A comparison of the cost effectiveness of...

  • Chemoradiotherapy for esophageal cancer: current status and perspectives. Ohtsu, Atsushi // International Journal of Clinical Oncology;Dec2004, Vol. 9 Issue 6, p444 

    The optimal role of chemoradiotherapy in the multimodality treatment of esophageal cancer is still controversial. According to a series of clinical trials, definitive chemoradiotherapy is considered the standard of care for patients with medically inoperable or surgically unresectable esophageal...

  • Barrett’s Esophagus, Fundoplication, and Cancer. Watson, David I.; Mayne, George C.; Hussey, Damian J. // World Journal of Surgery;Mar2007, Vol. 31 Issue 3, p447 

    The author reflects on the gastro-esophageal reflux and Barrett's esophagus. According to the author, gastro-esophageal reflux and Barrett's esophagus have become increasingly common in all Western countries, underpinning a 300-400% increase in the incidence of esophageal adenocarcinoma. The...

  • The Application of Prague C and M Criteria in the Diagnosis of Barrett's Esophagus in an Ethnic Chinese Population. Chi-Yang Chang; Yi-Chia Lee; Ching-Tai Lee; Chia-Hung Tu; Jau-C hung Hwang; Hung Chiang; Chi-Ming Tai; Tsung-H sien Chiang; Ming-Shiang Wu; Jaw-Town Lin // American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p13 

    OBJECTIVES: To investigate the prevalence of endoscopically suspected esophageal metaplasia (ESEM) in an ethnic Chinese population by endoscopic and pathologic evaluation and to assess the utility of Prague C and M criteria. METHODS: Consecutive patients who received esophagogastroduodenoscopy...


    Comments on the use of stents in the endoscopic management of esophagorespiratory fistulas. Information on the dysphagia symptom suffered by patients with esophageal cancer; Description of the Gianturco Z-stent and Wallstent mettalic stents; Efficacy of the stents.

  • Stent implantation as a treatment option in patients with thoracic anastomotic leaks after esophagectomy. Kauer, Werner K. H.; Stein, Hubert J.; Dittler, Hans-Joachim; Siewert, J. Rüdiger // Surgical Endoscopy;Jan2008, Vol. 22 Issue 1, p50 

    In patients with esophagectomy and gastric pull up for esophageal carcinoma anastomotic leaks are a well-known complication and a major cause of morbidity and mortality. We evaluated stent implantation as a treatment option in patients with thoracic anastomotic leaks after esophagectomy. 269...

  • Current and Future Options for Treating Esophageal Cancer. Hofstetter, Wayne // Texas Heart Institute Journal;2012, Vol. 39 Issue 6, p846 

    The article focuses on organ-sparing therapies for esophageal cancer. It relates the emergence of nonsurgical therapies for patients who do not have a surgical option. Examples of endoscopic therapy options for high-grade dysplasia and early cancers include endoscopic mucosal resection,...

  • What are the findings of esophageal cancer to be treated endoscopically? Kouzu, T.; Hishikawa, E.; Miyazaki, S. // Abdominal Imaging;Jul/Aug2003, Vol. 28 Issue 4, p0470 

    In Japan, the results of histopathologic analyses on esophageal carcinomas have shown that almost all of them are squamous epithelial cancers. The abnormal epithelium that is difficult to differentiate by endoscopy can be easily visualized by chromoendoscopy with the use of iodine staining....


Read the Article


Sign out of this library

Other Topics